Cilazapril
Names | |
---|---|
IUPAC name
(4S,7S)-7-[[(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.149.464 |
KEGG | |
PubChem CID |
|
UNII | |
| |
| |
Properties | |
C22H31N3O5 | |
Molar mass | 417.51 g·mol−1 |
log P | 2.212 |
Acidity (pKa) | 2.285 |
Basicity (pKb) | 11.712 |
Pharmacology | |
C09AA08 (WHO) | |
Oral | |
Legal status |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Cilazapril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure.[1][2] It is branded as Dynorm, Inhibace, Vascace and many other names in various countries. None of these are available in the United States as of May 2010.[3]
Of the eight possible stereoisomers, only the all-(S)-form is medically viable.
References
- ↑ Szucs, T. (1991). "Cilazapril. A review". Drugs. 41 Suppl 1: 18–24. PMID 1712267. doi:10.2165/00003495-199100411-00005.
- ↑ Jasek, W, ed. (2007). Austria-Codex (in German) (2007/2008 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4.
- ↑ "Cilazapril". Drugs.com. Retrieved 28 May 2010.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.